Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Gilead Sciences    GILD

GILEAD SCIENCES (GILD)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201520162017201820192020
Sales32 63930 39026 10721 26521 16721 839
EBITDA23 66820 347-11 86212 29212 196
Operating profit (EBIT)23 39620 03316 03111 28911 14011 430
Pre-Tax Profit (EBT)------
Net income18 10813 5014 6286 9757 2958 171
P/E ratio8,507,2020,415,414,512,5
EPS ( $ )11,99,943,515,255,586,44
Dividend per Share ( $ )1,291,842,082,252,432,46
Yield1,27%2,57%2,90%2,79%3,01%3,04%
Reference price ( $ )101.1971.6171.6480.780.780.7
Announcement Date02/02/2016
09:00pm
02/07/2017
09:01pm
02/06/2018
09:01pm
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201520162017201820192020
Debt7 573--16 88714 43614 570
Finance-32 38036 694---
Operating income (EBITDA)23 66820 347-11 86212 29212 196
Leverage
(Debt/EBITDA)
0,32x--1,42x1,17x1,19x
Capital Expenditure747748-596560570
Book Value Per Share (BVPS)13,2 $14,6 $15,7 $19,7 $20,2 $23,7 $
Cash Flow per Share12,9 $12,3 $-6,84 $7,32 $7,16 $
Announcement Date02/02/2016
09:00pm
02/07/2017
09:01pm
02/06/2018
09:01pm
---
Balance Sheet Analysis
Assessed data source :
© 2018 Thomson Reuters
Financial Ratios

Size 2018e 2019e
Capitalization 105 388 M$ -
Entreprise Value (EV) 122 275 M$ 119 824 M$
Valuation 2018e 2019e
P/E ratio (Price / EPS) 15,4x 14,5x
Capitalization / Revenue 4,96x 4,98x
EV / Revenue 5,75x 5,66x
EV / EBITDA 10,3x 9,75x
Yield (DPS / Price) 2,79% 3,01%
Price to book (Price / BVPS) 4,10x 4,00x
Profitability 2018e 2019e
Operating Margin (EBIT / Sales) 53,1% 52,6%
operating Leverage (Delta EBIT / Delta Sales) -1,59x -2,88x
Net Margin (Net Profit / Revenue) 32,8% 34,5%
ROA (Net Profit / Asset) 12,7% 14,2%
ROE (Net Profit / Equities) 39,9% 45,9%
Rate of Dividend 42,9% 43,5%
Balance Sheet Analysis 2018e 2019e
CAPEX / CA   2,80% 2,65%
Cash Flow / Sales 42,1% 45,3%
Capital Intensity (Assets / Sales) 2,58x 2,43x
Financial Leverage (Net Debt / EBITDA) 1,42x 1,17x
EPS & Dividend